exposing Parkinson's disease's voices and faces.

Published Date: 26 Apr 2023

One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.

Read Full News

Latest News

New Fall-Detection Tech Could Ease Nursing Workloads

AI-powered radar systems may alert staff before a fall happens, with early studies showing fewer falls and less strain on nursing teams.

Popular Joint Supplement Tied to Faster AD Progression

A new study links glucosamine use to faster progression from MCI to dementia and identifies glycan metabolism as a potential new therapeutic target in Alzheimer’s disease.

Huntington Therapy Faces Regulatory Roller Coaster

uniQure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of the one-time, invasive gene therapy AMT-130.

Simple Reflex Exam May Predict Future Dementia Risk

Multiple frontal release signs among cognitively normal older adults are associated with a higher risk for dementia and faster cognitive decline.

Beyond Amyloid: What’s in the Pipeline for Alzheimer’s?

Alzheimer’s drug development now targets tau, neuroinflammation, metabolism, and synaptic dysfunction — expanding beyond amyloid toward precision medicine and combination therapy.

Vomiting During Migraine Attacks Tied to Rapid Pain Relief

Vomiting during a migraine attack is associated with relief or freedom from pain in more than half of patients, a new study shows.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Todays Updates

Multiple Myeloma Patients Have Unequal Access to Treatment

Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.

e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?

A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.

Combination Treatment May Improve Multiple Myeloma Outcomes

Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.

Is There a Role for Stimulants in Beating Cancer Fatigue?

Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.

Latest News

AI-powered radar systems may alert staff before a fall happens, with early studies showing fewer falls and less strain on nursing teams.

A new study links glucosamine use to faster progression from MCI to dementia and identifies glycan metabolism as a potential new therapeutic target in Alzheimer’s disease.

uniQure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of the one-time, invasive gene therapy AMT-130.

Multiple frontal release signs among cognitively normal older adults are associated with a higher risk for dementia and faster cognitive decline.

Alzheimer’s drug development now targets tau, neuroinflammation, metabolism, and synaptic dysfunction — expanding beyond amyloid toward precision medicine and combination therapy.

Vomiting during a migraine attack is associated with relief or freedom from pain in more than half of patients, a new study shows.

News All Time

Most ‘Sleep-Divorced’ Couples Support Sleeping Separately

A study in Brazil reveals the prevalence and attitudes among couples not driven by relationship stress toward ‘sleep divorce’ arrangements.

Experimental Drug Cuts Migraine Days in Mid-stage Trial

Denmark's Lundbeck said on Thursday its experimental drug bocunebart cut monthly migraine days in ⁠a mid-stage study, supporting further development of a new type of...

Spinal Cord Treatment Triggers Hope and Lawsuits in Brazil

An experimental treatment for spinal cord injuries is drawing patients from as far as Mexico, mobilizing the government to expedite approval before its safety has been proven in a clinical trial.

Global Lewy Body Dementia Incidence: New Data

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher than that of other uncommon neurological disorders.

Comorbid Illness Common in Functional Neurologic Disorder

Functional neurologic disorder has a higher mortality rate than multiple sclerosis and often occurs with comorbid neurologic and psychiatric disorders, a new study shows.

First Clear Win for BTK Inhibitors in Relapsing MS

After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active comparator for relapsing MS outcomes.

Primary Care Making More Mental Health Diagnoses for Kids

Pediatric mental health visits in primary care surged over a 9-year period.

Electroacupuncture Promising for Cognitive Improvement in AD

Electroacupuncture was associated with long-term efficacy in improving cognitive function compared to sham treatment in patients with Alzheimer’s disease, a new trial shows.

Undiagnosed Dementia Tied to Increased Mortality Risk

Undiagnosed dementia is highly prevalent in the US and Brazil and is linked to increased 4-year mortality in both countries, a large cohort study shows.

Coffee Linked to Better Cognition in Patients With PD

Coffee consumption is associated with improved executive function in patients with early Parkinson’s disease, while smoking has no impact, a new study suggests.

How One Psilocybin Trip May Reshape the Brain

New research suggests a single high dose of psilocybin alters neural activity and may trigger lasting structural brain changes tied to improved well-being.

Brain Cooling Boosts LVO Recovery After Thrombectomy

Targeted intra-arterial cooling delivered during clot retrieval significantly increases functional independence after large-vessel ischemic stroke, with no added risk.

Optimal Sleep May Lower Dementia Risk in Focal Epilepsy

Optimal sleep duration is tied to better cognition and a lower risk for dementia in adults with focal epilepsy than in healthy individuals, new research shows.

AHA Reframes Brain Health as a Lifelong Process

A new AHA scientific statement says sleep, mental health, pollution, and childhood adversity can shape cognitive aging and dementia risk, underscoring that brain health is built across a lifetime.

A Stepwise Approach Can Support Healthy Sleep in Children

Minimize the use of medications that counteract melatonin as well as stimulating activities that trigger cortisol, one researcher advised.

Roche Gets Second European Approval for Alzheimer's Test

Swiss drugmaker Roche has received the CE mark - a ⁠European regulatory clearance allowing sale in the region - for its second ⁠Elecsys blood test for Alzheimer's disease.

Recommended News For You

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Higher levels of HIF2α found to slow down aggressive childhood cancer

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

New analysis helps discern benign from malignant thyroid growths

Lesser-known lobular breast cancer on the rise in U.S. women

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

Recommended Articles For You

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion 

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment 

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies 

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

2.

Survey: Record Numbers of US Adults Report Depression.

3.

Increased Exercise May Lower the Risk of Prostate Cancer.

4.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

5.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

1.

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment

2.

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy

3.

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy

4.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

5.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot